The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Axios Vitals on MSN49m
Funding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback